Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.